Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Pellagrous dermatitis, caused by niacin deficiency, can be cured with vitamin supplements.

A rare skin condition causes red, dark, bumpy facial lesions.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

Skin cells and immune cells change in a skin condition called hidradenitis suppurativa, and a certain treatment can improve these changes.

Lipedematous alopecia causes permanent hair loss due to increased scalp fat.

Chronic lupus and frontal fibrosing alopecia can occur together, but their connection is unclear.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

Early and accurate diagnosis of primary vitreoretinal lymphoma is crucial to prevent serious complications.

Lactic acid cream can help improve skin bumps known as eruptive vellus hair cysts.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Understanding related health issues in skin disease patients is crucial for better care.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Skin diseases are common in HIV patients and could help detect HIV early in Ethiopia.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Hair loss in Cronkhite-Canada syndrome may be caused by autoimmune factors, not just stress or malabsorption.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Mycophenolate mofetil may improve symptoms and stop hair loss in Lichen planopilaris, but more research is needed.

Men with systemic lupus erythematosus often have more severe symptoms but can respond well to treatment.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.